GLP-1 and GLP-1RA action have also been shown to improve systemic risk factors that affect kidneys, including inflammation, oxidative stress, and endothelial dysfunction (Fig. 1) (14, 123, 124). The gene discussed is GCG; the disease is endothelial dysfunction.